DNA-junction-based personalized liquid biopsy assays could inform management of aggressive endometrial cancer
- DOI
- 10.1016/j.ijgc.2025.102773
- Published
- 2026-05
- Container
- International Journal of Gynecological Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijgc.2025.102773,
title = {DNA-junction-based personalized liquid biopsy assays could inform management of aggressive endometrial cancer},
author = {Faye R. Harris and Luigi A. De Vitis and Leah Grcevich and Ilaria Capasso and Stephen J. Murphy and James B. Smadbeck and Alexa F. McCune and Mohamed F. Ali and Giannoula Karagouga and Sarah H. Johnson and Dorsay Sadeghian and Gabriella Schivardi and Giuseppe Cucinella and Evelyn A. Reynolds and Grace M. Choong and Lin Yang and Alyssa M. Larish and Michael T. Barrett and Angela R. Emanuel and Janet L. Schaefer-Klein and Farhad Kosari and Alan R. Penheiter and Tommaso Grassi and Sotiris Sotiriou and John Cheville and Ryan W. Feathers and Wan-Hsin Lin and Maureen Lemens and Mitesh J. Borad and Aaron S. Mansfield and Angela J. Fought and Michaela E. McGree and Panos Z. Anastasiadis and S John Weroha and Andrea Mariani and George Vasmatzis},
year = {2026},
journal = {International Journal of Gynecological Cancer},
doi = {10.1016/j.ijgc.2025.102773},
url = {https://doi.org/10.1016/j.ijgc.2025.102773}
}RIS
TY - JOUR TI - DNA-junction-based personalized liquid biopsy assays could inform management of aggressive endometrial cancer AU - Faye R. Harris AU - Luigi A. De Vitis AU - Leah Grcevich AU - Ilaria Capasso AU - Stephen J. Murphy AU - James B. Smadbeck AU - Alexa F. McCune AU - Mohamed F. Ali AU - Giannoula Karagouga AU - Sarah H. Johnson AU - Dorsay Sadeghian AU - Gabriella Schivardi AU - Giuseppe Cucinella AU - Evelyn A. Reynolds AU - Grace M. Choong AU - Lin Yang AU - Alyssa M. Larish AU - Michael T. Barrett AU - Angela R. Emanuel AU - Janet L. Schaefer-Klein AU - Farhad Kosari AU - Alan R. Penheiter AU - Tommaso Grassi AU - Sotiris Sotiriou AU - John Cheville AU - Ryan W. Feathers AU - Wan-Hsin Lin AU - Maureen Lemens AU - Mitesh J. Borad AU - Aaron S. Mansfield AU - Angela J. Fought AU - Michaela E. McGree AU - Panos Z. Anastasiadis AU - S John Weroha AU - Andrea Mariani AU - George Vasmatzis PY - 2026 JO - International Journal of Gynecological Cancer DO - 10.1016/j.ijgc.2025.102773 UR - https://doi.org/10.1016/j.ijgc.2025.102773 ER -
APA
Harris, F. R., Vitis, L. A. D., Grcevich, L., Capasso, I., Murphy, S. J., Smadbeck, J. B., McCune, A. F., Ali, M. F., Karagouga, G., Johnson, S. H., Sadeghian, D., Schivardi, G., Cucinella, G., Reynolds, E. A., Choong, G. M., Yang, L., Larish, A. M., Barrett, M. T., Emanuel, A. R., Schaefer-Klein, J. L., Kosari, F., Penheiter, A. R., Grassi, T., Sotiriou, S., Cheville, J., Feathers, R. W., Lin, W., Lemens, M., Borad, M. J., Mansfield, A. S., Fought, A. J., McGree, M. E., Anastasiadis, P. Z., Weroha, S. J., Mariani, A., & Vasmatzis, G. (2026). DNA-junction-based personalized liquid biopsy assays could inform management of aggressive endometrial cancer. International Journal of Gynecological Cancer. https://doi.org/10.1016/j.ijgc.2025.102773
Source records
- crossref · retrieved 2026-09-26T14:31:08.771Z